THE LETHAL ACTIVITY OF PLATINUM COMPOUNDS IN COMBINATION WITH PYRIMIDINE DERIVATIVES
Authors:
- Benjamin DrewinkoBDBenjamin Drewinko
- Peter CorryPCPeter Corry
- John-Pierre BergeratJBJohn-Pierre Bergerat
- Barthel BarlogieBBBarthel Barlogie
- 1 January 1980
- book chapter
- Published by Elsevier
- p. 37-55
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Patterns of cell survival following treatment with antitumor agents in vitro1979
- Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing HeLa cells in the absence and presence of caffeineChemico-Biological Interactions, 1978
- Further Biologic Characteristics of a Human Carcinoembryonic Antigen-Producing Colon Carcinoma Cell Line2JNCI: Journal of the National Cancer Institute, 1978
- Postreplication Repair of Ultraviolet Damage to DNA, DNA-Chain Elongation, and Effects of Metabolic Inhibitors in Mouse L CellsBiophysical Journal, 1975
- The effect of cis-dichlorodiammineplatinum(II) on Escherichia coli B the role of fil, exr and hcr markersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973
- New platinum complexes with anti-tumour activityChemico-Biological Interactions, 1972
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966